We are live on ! Find out more
BSW

Buckingham Strategic Wealth Portfolio holdings

AUM $9.66B
1-Year Est. Return 15.76%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+15.76%
3 Year Est. Return
+16.25%
5 Year Est. Return
+59.71%
10 Year Est. Return
+173.87%
AUM
$5.5B
AUM Growth
+$604M
Cap. Flow
+$163M
Cap. Flow %
2.95%
Top 10 Hldgs %
59.21%
Holding
671
New
57
Increased
228
Reduced
293
Closed
40

Sector Composition

Rank Sector Weight
1 Technology 3.28%
2 Financials 2.47%
3 Industrials 2.43%
4 Healthcare 2.05%
5 Consumer Discretionary 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
476
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$310K 0.01%
2,192
+143
+7% +$20K
JEF icon
477
Jefferies Financial Group
JEF
$13.1B
$308K 0.01%
9,405
-1,205
-11% -$40K
PEG icon
478
Public Service Enterprise Group
PEG
$37.7B
$307K 0.01%
5,018
-1,278
-20% -$74.2K
XBI icon
479
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$307K 0.01%
+3,702
New +$300K
VIGI icon
480
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$306K 0.01%
+4,395
New +$296K
KXI icon
481
iShares Global Consumer Staples ETF
KXI
$1.07B
$304K 0.01%
5,105
DLN icon
482
WisdomTree US LargeCap Dividend Fund
DLN
$6.39B
$303K 0.01%
4,897
BEP icon
483
Brookfield Renewable
BEP
$9.96B
$303K 0.01%
+11,962
New +$341K
NVO
484
Novo Nordisk
NVO
$209B
$302K 0.01%
+4,456
New +$261K
STX icon
485
Seagate
STX
$184B
$297K 0.01%
5,643
+73
+1% +$3.88K
HUM icon
486
Humana
HUM
$46.2B
$296K 0.01%
578
-45
-7% -$23.7K
WTW icon
487
Willis Towers Watson
WTW
$32B
$295K 0.01%
1,205
+1
+0.1% +$228
LBC
488
DELISTED
Luther Burbank Corporation Common Stock
LBC
$294K 0.01%
26,479
-5,959
-18% -$70K
GSK icon
489
GSK
GSK
$106B
$293K 0.01%
8,352
-3,656
-30% -$122K
PCT icon
490
PureCycle Technologies
PCT
$1.45B
$293K 0.01%
43,310
-33,639
-44% -$243K
PPL
491
PPL Corp
PPL
$26.7B
$288K 0.01%
9,851
-13
-0.1% -$357
WEC icon
492
WEC Energy
WEC
$35.1B
$286K 0.01%
3,049
-204
-6% -$18.9K
OKE icon
493
Oneok
OKE
$54.5B
$286K 0.01%
4,346
+7
+0.2% +$430
RF icon
494
Regions Financial
RF
$26.8B
$285K 0.01%
13,209
-1,762
-12% -$38.2K
TEVA icon
495
Teva Pharmaceuticals
TEVA
$41.2B
$285K 0.01%
31,210
-700
-2% -$6.11K
WMS icon
496
Advanced Drainage Systems
WMS
$10.9B
$280K 0.01%
3,417
+155
+5% +$15.7K
J icon
497
Jacobs Solutions
J
$17B
$279K 0.01%
2,812
+25
+0.9% +$2.46K
DBEF icon
498
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$278K 0.01%
8,633
FHLC icon
499
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
$277K 0.01%
4,333
-491
-10% -$30.7K
DOV icon
500
Dover
DOV
$28.4B
$277K 0.01%
2,042
-66
-3% -$8.77K

Similar funds

Buckingham Strategic Wealth's Q4 2022 Portfolio in Review

As of Q4 2022, Buckingham Strategic Wealth held 671 positions worth $5.5B, up 12% from $4.9B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Buckingham Strategic Wealth's Q4 2022 filing shows 57 new, 228 increased, 293 reduced and 40 closed positions. Its largest new stake was ProShares S&P MidCap 400 Dividend Aristocrats ETF: 22,049 shares worth $1.58M. The largest sale was Vanguard Short-Term Inflation-Protected Securities Index Fund, an estimated $5.58M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.6% a quarter earlier, followed by Financials and Industrials.

  • Buckingham Strategic Wealth's largest Q4 2022 buy was ProShares S&P MidCap 400 Dividend Aristocrats ETF: 22,049 shares worth $1.58M.
  • Buckingham Strategic Wealth added most to Dimensional US Targeted Value ETF in Q4 2022, an estimated $29.7M increase.
  • Buckingham Strategic Wealth's biggest Q4 2022 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $5.58M.
  • Buckingham Strategic Wealth fully exited Immuneering in Q4 2022, selling an estimated $2.87M.
  • Buckingham Strategic Wealth's ten largest holdings make up 59% of its $5.5B portfolio in Q4 2022.
  • Buckingham Strategic Wealth opened 57 new positions and closed 40 in Q4 2022.
  • Buckingham Strategic Wealth's portfolio value rose 12% quarter-over-quarter to $5.5B.

Based on Buckingham Strategic Wealth's 13F filing for Q4 2022, filed 13 Feb 2023.